Distribution and treatment of cardiovascular risk factors in coronary patients: The PREVENIR study;Distribution et prise en charge des facteurs de risque cardiovasculaires chez des patients coronariens: Étude Prévenir

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 7, 2001, Pages 673-680

  Marques Vidal, P ^a   Cambou, J P ^a   Ferrieres, J ^a   Thomas, D ^b   Grenier, O ^c   Cantet, C ^a   Danchin, N ^d  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hopital Boucicaut   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; DYSLIPIDEMIA; FEMALE; FRANCE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; SMOKING; UNSTABLE ANGINA PECTORIS;

EID: 0010445906     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Evolution épidémiologique des maladies cardiovasculaires dans les pays en dévelopement
2. The burden of cardiovascular diseases mortality in Europe
3. Épidémiologie à l'échelle. Européenne et française de l'infarctus du myocarde
4. Emerging epidemic of cardiovascular disease in developing countries
5. Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study
6. Classical risk factors and emerging elements in the risk profile for coronary artery disease
7. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S)
8. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
9. Sixième rapport du Joint National Committee sur la Prévention, la détection, l'évaluation et le traitement de l'hypertension artérielle
10. Impact of major cardiovascular disease, risk factors, particularly, in combination, on 22-year mortality in women and men
11. The Münster Heart Study (PROCAM)
12. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring trends and determinants in cardiovascular diseases
13. Clustering of metabolic factors and coronary heart disease
14. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial
15. The association of changes in physical activity level and other lifestyle characteristics with mortality among men
16. The multifactor primary prevention trial in Göteborg, Sweden
17. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men
18. Pronostic de l'infarctus du myocarde chez le patient diabétique: Résultats de l'étude épidémiologique USIK
19. Epidémiologie de l'infarctus du myocarde en France. Spécificités régionales
20. Prevalence et prise en charge des facteurs de risque majeurs chez 500 prise présentant une maladie coronaire stable
21. Dietary fat and risk of coronary heart disease in men: Cohort follow up study in the United States
22. Clustering of cardiovascular risk factors: Targeting high-risk individuals
23. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
24. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals
25. Awareness and control of hypertension and hypercholesterolaemia in France and Northern Ireland
26. Awareness and management of hypercholesterolemia and hypertension in France and Northern Ireland
27. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992
28. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
29. Scandinavian Simvastatin study - Comments
30. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
31. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
32. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia
33. Cholesterol awareness and case-finding: Do patients really know their cholesterol numbers?
34. Effects of practice settings on quality of lipid-lowering manaqement in patients with coronary artery disease
35. Prise en charge des facteurs de risque après une maladie coronaire dans les pays européens